Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN): "pressure on Legend shares... overdone"

March 6, 2026 3:42 PM EST Send to a Friend
Raymond James analyst Sean McCutcheon reiterated an Outperform rating on Legend Biotech Corp. (NASDAQ: LEGN)The analyst commented, "Thursday, JNJ announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login